Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021
Tue, November 9, 2021
Mon, November 8, 2021
Sun, November 7, 2021
Fri, November 5, 2021
Thu, November 4, 2021

Emmanuel Papadakis Maintained (BNTX) at Hold and Held Target at $225 on, Nov 9th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-225-on-nov-9th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold and Held Target at $225 on, Nov 9th, 2021.

Emmanuel has made no other calls on BNTX in the last 4 months.



There are 6 other peers that have a rating on BNTX. Out of the 6 peers that are also analyzing BNTX, 4 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Akash Tewari of "Jefferies" Initiated at Hold and Held Target at $230 on, Thursday, October 7th, 2021
  • Daina Graybosch of "SVB Leerink" Maintained at Hold with Decreased Target to $268 on, Tuesday, October 5th, 2021
  • Eliana Merle of "UBS" Maintained at Hold with Increased Target to $300 on, Friday, August 27th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Hold with Increased Target to $330 on, Wednesday, August 11th, 2021


These are the ratings of the 2 analyists that currently disagree with Emmanuel


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $450 on, Friday, August 20th, 2021
  • Olga Smolentseva of "Bryan Garnier" Upgraded from Hold to Strong Buy and Held Target at $451 on, Wednesday, August 11th, 2021

Publication Contributing Sources